WHAT IS REGENERATIVE MEDICINE?
Overtime the healthy tissues in our bodies can breakdown and degenerate due to age and injury.
As we age, our bodies' abilities to self-repair diminishes, leading to pain and discomfort.
Regenerative medicine uses human cells and tissue products to repair, cushion and replace injured areas and help the body’s natural healing process.
Once the human cells are introduced to the affected area, they get to work immediately, working with our own body’s cells to help us heal and recover faster.
Stem cells are a human’s basic building blocks. These cells have the ability to replenish, replace, repair, and cushion an injured area. Due to stem cells being unspecialized, they can be introduced into an area of the body and become specialized based on the body’s needs. Stem cells injected into an area will enter a complex signaling mode. Once this occurs, your body will naturally respond to those signals by sending the necessary cells to help repair and engage in the healing process. The body will release growth factors, cytokines, scaffolding cells, etc. in order to respond to the body’s specific needs.
EFFECTIVENESS & ADMINISTRATION
Stem cells are effective in reducing inflammation, promoting faster healing, and seeking out degeneration. Stem cells can be administered intra-articular or intravenous (I.V.). Our products are anti-inflammatory, anti-microbial, anti-fibrotic, and evoke an immunomodulatory response.
STROMAL MESENCHYMAL STEM CELLS & PLACENTAL TISSUE
Our products are FDA-compliant. Our products are procured from placental tissue and the Wharton’s jelly layer of the umbilical cord. All our products are from ethically-sourced, donated birthing tissues. They are derived from full-term healthy caesarean-section deliveries. 3rd party independent testing lab to verify all of the products viability, sterility, and sustainability. Comprehensive medical and social background checks of all our donors are performed to exceed the standards set by the FDA. Our products are approved to be used in the same way the patient’s own tissue functions, thus aiding in recovery. These products do not contain any embryonic or fetal tissue.
FDA ON STEM CELLS
Umbilical cord tissue has been formally recognized and mentioned under human cell and tissue products (HCT/P) guidance 361
Umbilical cord tissue has been classified as a “structural tissue”
Homologous use for umbilical cord tissue is defined as “to cushion and protect and having the utility for repair, reconstruction and replacement”
Cord blood products are now defined exclusively and only as Hematopoietic Stem Cells (HSCs).
Homologous use for cord blood is now defined as “forming and replenishing the lympho-hematopoietic system”